Partnerships |
APUA is pleased to acknowledge its supporters and partners in “preserving the power of antibiotics®.” APUA programs are funded through multi-year contracts and grants, professional societies and other major foundations, along with unrestricted grants from private corporations. APUA Corporate SponsorsLeadership Level-$25,000"A world leader in the field of in vitro diagnostics for over 45 years, bioMérieux is present in more than 150 countries through 39 subsidiaries and a large network of distributors. bioMérieux’s mission is to play a major role in the fight against infectious disease in clinical biology by:
"A leading manufacturer founded in 1980. Today Clorox has 8,300 employees worldwide and the company manufactures products in over 24 countries and markets them in more than 100 countries." Benefactor Level-$15,000
"We are a global research-based biopharmaceutical company. Our skills and resources are focused on discovering, developing and marketing medicines for some of the world’s most serious illnesses, including cancer, heart disease, neurological disorders such as schizophrenia, respiratory disease and infection."
"At Alere Inc., we believe that people all over the world want to be involved in their own healthcare while remaining in their homes and that, when they do so, they have an improved quality of life. Our primary areas of focus are cardiology, infectious disease, women’s health, oncology and toxicology." Partner Level-$10,000
Bayer Healthcare Pharmaceuticals
"Bayer is an inventor company with a long tradition of research. By applying science to the major global challenges, we deliver innovations that address unmet customer and market needs."
Alcon Laboratories
"Every day, we challenge ourselves with Alcon's mission – to help people worldwide see better. As the leader in eye care, this mission means that we strive to make significant contributions in the fight to prevent and, one day, eliminate blindness. To that end, we are dedicated to providing the highest quality eye care products for treating various eye diseases and eye conditions."
GlaxoSmithKline
“Headquartered in the UK and with operations based in the US, we are one of the industry leaders, with an estimated seven percent of the world's pharmaceutical market.” Supporting Level
Paratek Pharmaceuticals
"Paratek Pharmaceuticals, Inc. is a privately held biopharmaceutical company headquartered in Boston, MA, which is engaged in the discovery and commercialization of new therapeutics that treat life threatening infectious and other serious diseases." Pro bono legal services provided by Holland & Knight, LLP
Page last updated February 2012 |








